Financhill
Back

Lyell Immunopharma Stock Predictions

Lyell Immunopharma Stock Forecast

  • Is Lyell Immunopharma Stock Undervalued?
    The current Lyell Immunopharma [LYEL] share price is $1.36. The Score for LYEL is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • LYEL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Lyell Immunopharma Stock Go Up Next Year?

Data Unavailable

Lyell Immunopharma Stock Rating

Data Unavailable

Lyell Immunopharma Stock Price History

Is LYEL stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
lyell.com

52-Week Data

52-Week High:
3.26
52-Week Low:
1.09

Prediction Charts

Market Cap:
348.16M
Price in USD:
1.36
Volume:
628.16K
Beta:
-0.54

Technical Analysis

SMA50:
1.46
SMA100:
1.88
SMA200:
2.01
52-Wk Change:
-16.05%

Stock Predictions

  • Is Lyell Immunopharma stock public?
    Yes, Lyell Immunopharma is a publicly traded company.
  • What is the Lyell Immunopharma stock quote today?
    The Lyell Immunopharma stock price is 1.36 USD today.
  • How to buy Lyell Immunopharma stock online?
    You can buy Lyell Immunopharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Aug-30 1.45 1.45 1.50 1.42
Sep-3 1.46 1.40 1.51 1.37
Sep-4 1.39 1.38 1.43 1.34
Sep-5 1.39 1.28 1.39 1.28
Sep-6 1.25 1.16 1.27 1.15
Sep-9 1.18 1.13 1.18 1.12
Sep-10 1.14 1.15 1.16 1.09
Sep-11 1.15 1.15 1.19 1.10
Sep-12 1.17 1.15 1.19 1.11
Sep-13 1.20 1.23 1.23 1.16
Sep-16 1.22 1.24 1.28 1.18
Sep-17 1.28 1.39 1.41 1.21
Sep-18 1.39 1.36 1.43 1.31
Sep-19 1.42 1.56 1.60 1.40

Lyell Immunopharma Earnings

Data Unavailable

Lyell Immunopharma Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $0.04 per share.

* Lyell Immunopharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.